Program death inhibitors in classical Hodgkin’s lymphoma: a comprehensive review

Reyad Dada
  • Annals of Hematology, January 2018, Springer Science + Business Media
  • DOI: 10.1007/s00277-017-3226-0
The author haven't finished explaining this publicationThe author haven't finished explaining this publication
Read Publication

http://dx.doi.org/10.1007/s00277-017-3226-0

The following have contributed to this page: Reyad Dada

In partnership with: